FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

American woman missing after husband says she fell overboard, swept to sea during Bahamas boat trip: police

Newsom’s California rail project now expected to cost $126B, official admits, with still no tracks laid

Israel hits South Pars natural gas field as Trump deadline looms

Children of Illegal Aliens Linked to Attempted Bombing at U.S. Air Force Base

Martinez: Why President Trump’s War On Fraud Exposes National Scandal

Ceasefire proposal could reopen key oil route amid US-Iran tensions and more top headlines

Behind ‘No Kings’ St. Paul protest: $250K production machine equal to a Def Leppard concert

Lindsey Graham turns ire toward rivals at home amid Iran and DHS shutdown fallout

Iranian intelligence chief and militia commander among those killed in Israeli strikes

GOP races to pass ICE, Border Patrol funding bill as priorities pile up, divisions emerge

Why the Strait of Hormuz matters as Trump issues fresh ultimatum to Iran

Pair of Democrat lawmakers slam ‘blockade of fuel’ to Cuba, ‘economic bombing’ after visit to island

New Hampshire suspect who shot officer and triggered massive manhunt killed in police gunfight

Savannah Guthrie’s Easter message reveals anguish as mom missing 63 days

Greene says Trump isn’t Christian in slamming Easter threat to reopen Strait of Hormuz

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”